A review of drug-induced liver injury databases

被引:35
|
作者
Luo, Guangwen [1 ]
Shen, Yiting [1 ]
Yang, Lizhu [1 ]
Lu, Aiping [2 ]
Xiang, Zheng [1 ,2 ]
机构
[1] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Peoples R China
[2] Hong Kong Baptist Univ, Inst Adv Translat Med Bone & Joint Dis, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China
关键词
Review; Databases; Drug-induced liver injury; Hepatotoxicity; Liver toxicity; SCALE TOXICOGENOMICS DATABASE; INDUCED HEPATOTOXICITY; ACETAMINOPHEN HEPATOTOXICITY; COMBINATION THERAPY; IN-VITRO; TOXICITY; RISK; EXPRESSION; MODEL; RATS;
D O I
10.1007/s00204-017-2024-8
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Drug-induced liver injuries have been a major focus of current research in drug development, and are also one of the major reasons for the failure and withdrawal of drugs in development. Drug-induced liver injuries have been systematically recorded in many public databases, which have become valuable resources in this field. In this study, we provide an overview of these databases, including the liver injury-specific databases LiverTox, LTKB, Open TG-GATEs, LTMap and Hepatox, and the general databases, T3DB, DrugBank, DITOP, DART, CTD and HSDB. The features and limitations of these databases are summarized and discussed in detail. Apart from their powerful functions, we believe that these databases can be improved in several ways: by providing the data about the molecular targets involved in liver toxicity, by incorporating information regarding liver injuries caused by drug interactions, and by regularly updating the data.
引用
收藏
页码:3039 / 3049
页数:11
相关论文
共 50 条
  • [31] Drug-induced liver injury: what was new in 2013?
    Chalhoub, Walid M.
    Sliman, Kayla D.
    Arumuganathan, Meera
    Lewis, James H.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (07) : 959 - 980
  • [32] Chemical probes for drug-induced liver injury imaging
    Jiang, Tao
    Rong, Pengfei
    Wang, Wei
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (09) : 835 - 852
  • [33] Pregnane X receptor and drug-induced liver injury
    Wang, Yue-Ming
    Chai, Sergio C.
    Brewer, Christopher T.
    Chen, Taosheng
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (11) : 1521 - 1532
  • [34] Prediction of drug-induced liver injury using keratinocytes
    Hirashima, Rika
    Itoh, Tomoo
    Tukey, Robert H.
    Fujiwara, Ryoichi
    JOURNAL OF APPLIED TOXICOLOGY, 2017, 37 (07) : 863 - 872
  • [35] Incidence and risk factors of drug-induced liver injury
    Li, Xiaoyun
    Tang, Jieting
    Mao, Yimin
    LIVER INTERNATIONAL, 2022, 42 (09) : 1999 - 2014
  • [36] Assessment of Reactive Metabolites in Drug-Induced Liver Injury
    Lee, Kye Sook
    Oh, Soo Jin
    Kim, Hwan Mook
    Lee, Ki Ho
    Kim, Sang Kyum
    ARCHIVES OF PHARMACAL RESEARCH, 2011, 34 (11) : 1879 - 1886
  • [37] Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
    Proctor, William R.
    Foster, Alison J.
    Vogt, Jennifer
    Summers, Claire
    Middleton, Brian
    Pilling, Mark A.
    Shienson, Daniel
    Kijanska, Monika
    Stroebel, Simon
    Kelm, Jens M.
    Morgan, Paul
    Messner, Simon
    Williams, Dominic
    ARCHIVES OF TOXICOLOGY, 2017, 91 (08) : 2849 - 2863
  • [38] Drug-induced liver injury: what was new in 2008?
    Liss, Gordon
    Lewis, James H.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (08) : 843 - 860
  • [39] The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury
    Thakkar, Shraddha
    Chen, Minjun
    Fang, Hong
    Liu, Zhichao
    Roberts, Ruth
    Tong, Weida
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (01) : 31 - 38
  • [40] Drug-induced Liver Injury Caused by Intravenously Administered Medications: The Drug-induced Liver Injury Network Experience
    Ghabril, Marwan
    Fontana, Robert
    Rockey, Don
    Jiezhun, Gu
    Chalasani, Naga
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (06) : 553 - 558